These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7141384)

  • 1. Host defense mellitus: defective membrane synthesis during phagocytosis.
    Subbaiah PV; Bagdade JD
    Horm Metab Res; 1982 Sep; 14(9):445-8. PubMed ID: 7141384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The appearance of lecithin- 32 P, synthesized from lysolecithin- 32 P, in phagosomes of polymorphonuclear leukocytes.
    Elsbach P; Patriarca P; Pettis P; Stossel TP; Mason RJ; Vaughan M
    J Clin Invest; 1972 Jul; 51(7):1910-4. PubMed ID: 4338124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
    Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
    Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phagocytosis, bactericidal capacity, and superoxide anion (O2-) production by polymorphonuclear neutrophils from patients with diabetes mellitus.
    Wierusz-Wysocka B; Wysocki H; Wykretowicz A; Szczepanik A; Siekierka H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):658-68. PubMed ID: 2416642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased lecithin synthesis during phagocytosis by normal leukocytes and by leukocytes of a patient with chronic granulomatous disease.
    Elsbach P; Zucker-Franklin D; Sansaricq C
    N Engl J Med; 1969 Jun; 280(24):1319-22. PubMed ID: 5814307
    [No Abstract]   [Full Text] [Related]  

  • 6. Phagocytosis--the mighty weapon of the silent warriors.
    Djaldetti M; Salman H; Bergman M; Djaldetti R; Bessler H
    Microsc Res Tech; 2002 Jun; 57(6):421-31. PubMed ID: 12112425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Various indicators of nonspecific immunity in diabetic patients with acute appendicitis].
    Grishchenko EE
    Vestn Khir Im I I Grek; 1990 Feb; 144(2):42-4. PubMed ID: 2165678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polimorphonuclear leukocytes and diabetes mellitus].
    Hopps E; Camera A; Caimi G
    Minerva Med; 2008 Apr; 99(2):197-202. PubMed ID: 18431327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired granulocyte function in patients with diabetes mellitus.
    Kaneshige H; Endoh M; Tomino Y; Nomoto Y; Sakai H; Arimori S
    Tokai J Exp Clin Med; 1982 Jan; 7(1):77-80. PubMed ID: 7080109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phagocytic activity of neutrophils improves over the course of therapy of diabetic foot infections.
    Top C; Yildiz S; Oncül O; Qydedi T; Cevikbaş A; Soyogul UG; Cavuşlu S
    J Infect; 2007 Oct; 55(4):369-73. PubMed ID: 17675245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphonuclear cell-mediated phagocytosis and superoxide anion release in insulin-dependent diabetes mellitus.
    Serlenga E; Garofalo AR; De Pergola G; Ventura MT; Tortorella C; Antonaci S
    Cytobios; 1993; 74(298-299):189-95. PubMed ID: 8404029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Residual urine and phagocytic activity of polymorphonuclear cells in diabetes].
    Sorf M; Krislo V; Bartek J; Krsák S
    Vnitr Lek; 1989 Sep; 35(9):899-902. PubMed ID: 2683367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of diabetes mellitus vs. in vitro hyperglycemia on select immune cell functions.
    Daoud AK; Tayyar MA; Fouda IM; Harfeil NA
    J Immunotoxicol; 2009 Mar; 6(1):36-41. PubMed ID: 19519161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytic function of polymorphonuclear leukocytes in essential mixed cryoglobulinaemia.
    Capsoni F; Vezio M; Meroni PL; Riboldi PS; Invernizzi F
    Boll Ist Sieroter Milan; 1982; 61(5):404-10. PubMed ID: 6765381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phagocytic function of polymorphonuclear leukocytes in various forms of diabetes mellitus].
    Zalevskaia AG; Burina MK; Blagosklonnaia IaV
    Probl Endokrinol (Mosk); 1981; 27(4):24-6. PubMed ID: 6794023
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence assay to monitor phagocytosis by blood-clot derived polymorphonuclear leucocytes. 1. Study of patients with diabetes and phagocytosis of different staphylococcal species.
    Musclow CE; Farkas-Himsley H; Durbahn G; Spragg L
    Cytobios; 1991; 65(260):15-24. PubMed ID: 2055102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of phagocytosis on sialidase activity of normal and diabetic polymorphonuclear leukocytes.
    Upadhyay A; Sircar K; Nath N
    Indian J Biochem Biophys; 1986 Apr; 23(2):121-2. PubMed ID: 3095223
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of the morphine analogue levorphanol on leukocytes. Metabolic effects at rest and during phagocytosis.
    Wurster N; Elsbach P; Simon EJ; Pettis P; Lebow S
    J Clin Invest; 1971 May; 50(5):1091-9. PubMed ID: 4928264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A defect in cell-mediated immune function in insulin-resistant diabetic and obese subjects.
    Kolterman OG; Olefsky JM; Kurahara C; Taylor K
    J Lab Clin Med; 1980 Sep; 96(3):535-43. PubMed ID: 6995542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.